 open double-blind long-term studi vigabatrin chronic epilepsi open double-blind long-term studi vigabatrin gamma-vinyl-gaba gvg patient treatment-resist epilepsi standard antiepilept drug a novel design parallel double-blind placebo-control phase number patient placebo determin optimum dose gvg patient initi double-blind phase studi phase first phase period baselin observ second phase gvg previou a week first week phase dose gvg absenc advers effect constant next week end open phase seizur frequenc week constant treatment baselin seizur frequenc patient patient reduct frequenc seizur type open phase respond respond third double-blind phase wither activ gvg treatment placebo week thirty-thre patient studi patient initi open phase patient reduct equal frequenc seizur type elig double-blind phase gvg